Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6300
Last updated 2011-08-19
Summary
The purpose of this study is to determine the degree of indirect benefits to family members and classmates resulting from administration of influenza vaccine to children.
Conditions
- Influenza Virus Infection
- Influenza-like Illness
- Acute Respiratory Infection
Interventions
- BIOLOGICAL
-
Trivalent live attenuated seasonal influenza vaccine
One dose
- BIOLOGICAL
-
Monovalent live attenuated pandemic influenza vaccine
One dose
- BIOLOGICAL
-
Saline
One dose
Sponsors & Collaborators
-
The University of Hong Kong
lead OTHER
Principal Investigators
-
Benjamin J Cowling, PhD · The University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- Hong Kong
More Related Trials
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric Population
NCT04963166 ·Status: COMPLETED
-
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children
NCT00900991 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05144464 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
NCT02741843 ·Status: COMPLETED ·Phase: NA
-
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 ·Status: COMPLETED ·Phase: NA
-
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Flu Vaccine in Children
NCT00001127 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
NCT00192218 ·Status: COMPLETED ·Phase: PHASE4
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051 ·Status: COMPLETED ·Phase: NA
-
Brief Influenza Vaccine Education to Pregnant Women
NCT01772901 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
NCT01967368 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age
NCT00158665 ·Status: COMPLETED ·Phase: NA
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
NCT00934245 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
NCT00138385 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
NCT03816878 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
NCT00980005 ·Status: COMPLETED ·Phase: PHASE3
-
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
NCT01310413 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population
NCT01007201 ·Status: COMPLETED ·Phase: NA